Transparent Products
Projected Capacitive and Resistive Touchscreens for Medical Devices
The European Union's (EU's) Seventh Framework Programme (FP7/ 2007-2013), under grant agreement number 304961, is providing €4.2m for the design and development of a biomimetic bioartificial liver (Re-Liver) that could be used as minimally invasive transplantation therapy for treating metabolic diseases such as hemophilia A.
The European Union’s (EU’s) Seventh Framework Programme (FP7/ 2007-2013), under grant agreement number 304961, is providing €4.2m for the design and development of a biomimetic bioartificial liver (Re-Liver) that could be used as a minimally invasive transplantation therapy for treating metabolic diseases such as hemophilia A.
A consortium of the universities of Manchester, Pisa, the Electrospinning Company and Medicyte will undertake the development of Re-Liver.
The collaborators aim to reconstitute a standardised, reproducible bioartificial liver organoid (BLO) using healthy human liver as an architectural and biomaterial template.
The BLO is a cell-based complex medicinal product, according to the European Medicines Agency criteria.
In addition, new diagnostic tools and further products in cell-based applications will be developed and validated by the Re-Liver collaborators.
Re-Liver consortium coordinator and Medicyte CEO and CSO, Joris Braspenning, said the combination of complimentary areas of expertise will give a deeper insight into the complex bioartificial liver design, but is also an approach to develop better and quicker diagnostic tools and cell-based products.
"This will be of great benefit for tomorrow’s advanced therapies and of course for patients suffering from liver diseases," Braspenning added.
The EU includes 6% of the population suffering from chronic liver diseases and scientists are experiencing several limitations with replacing livers, as therapeutic approaches are making it impossible.
In-vitro and ex-vivo technologies for recapitulating liver function are falling short of reliability, consistency and predictability, as well as suitable donor livers for solid organ transplant being in short supply.
Projected Capacitive and Resistive Touchscreens for Medical Devices
Innovative Solutions for Equipment that Demand Accurate High-Speed Repetitive Motion
High-Performance Composite Solutions and 3D Additive Manufacturing